Study of AVZO-021 in Patients With Advanced Solid Tumors
Conditions
Advanced Solid Tumor · HR+/HER2- Breast Cancer · HR+, HER2-, Advanced Breast Cancer · CCNE1 Amplification · Epithelial Ovarian Cancer · Primary Peritoneal Cancer · Fallopian Tube Cancer · Endometrial Cancer · TNBC - Triple-Negative Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Yale Cancer Center, New Haven, Connecticut, United States
Contact: Study coordinator (Yale Cancer Center)Florida Cancer Specialists, Sarasota, Florida, United States
Contact: Study coordinator (Florida Cancer Specialists)Moffitt Cancer Center, Tampa, Florida, United States
Contact: Study coordinator (Moffitt Cancer Center)Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola, New York, United States
Contact: Study coordinator (Perlmutter Cancer Center at NYU Langone Hospital - Long Island)NYU Langone Medical Center (Tisch Hospital), New York, New York, United States
Contact: Study coordinator (NYU Langone Medical Center (Tisch Hospital)University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
Contact: Study coordinator (University Hospitals Cleveland Medical Center)Oklahoma University, Oklahoma City, Oklahoma, United States
Contact: Study coordinator (Oklahoma University)Providence Cancer Institute, Portland, Oregon, United States
Contact: Study coordinator (Providence Cancer Institute)Sidney Kimmel Cancer Center (SKCC) at Jefferson Health, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Sidney Kimmel Cancer Center (SKCC)Texas Oncology - DFW, Dallas, Texas, United States
Contact: Study coordinator (Texas Oncology - DFW)NEXT Virginia, Fairfax, Virginia, United States
Contact: Study coordinator (NEXT Virginia)Macquarie University Hospital, Macquarie University, New South Wales, Australia
Contact: Study coordinator (Macquarie University Hospital)Cancer Care Wollongong, Wollongong, New South Wales, Australia
Contact: Study coordinator (Cancer Care Wollongong)